Erik Hellman

Erik Hellman is a seasoned finance professional currently serving as a Senior Manager in Financial Planning & Analysis (FP&A) at Corcept Therapeutics since November 2020, where responsibilities include the preparation of monthly reporting packages and support for forecasts and annual budgets. Prior experience includes positions as a Finance Consultant at AstraZeneca, where work involved reconciling liabilities for Oncology studies, and various finance roles at companies such as Thin Film Systems, Vocera Communications, and Matterport, focusing on financial modeling, forecasting, and supporting executive reporting processes. Erik holds an MBA from Santa Clara University and a BA in Business Economics from UC Santa Barbara. Proficient in financial systems including MS Office and Oracle, Erik has developed strong analytical and communication skills throughout a diverse career in corporate finance.